Galecto Completes Dosing in 52-Week Phase 2b GALACTIC-1 Trial of GB0139 in Idiopathic Pulmonary Fibrosis
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
News
Celularity Announces $45 Million Purchase Order, First Middle East Private Label Agreement For Celularity’s Halal-Certified Biomaterial Products
Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and…
Celularity Announces $45 Million Purchase Order, First Middle East Private Label Agreement For Celularity’s Halal-Certified Biomaterial Products
Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and…
T2 Biosystems Announces First Quarter 2023 Financial Results
Filed FDA submission for T2Biothreat Panel, implemented a restructuring program and announced exploration of strategic…
T2 Biosystems Announces First Quarter 2023 Financial Results
Filed FDA submission for T2Biothreat Panel, implemented a restructuring program and announced exploration of strategic…
T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Ocugen to Present at BIO International Convention 2023
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Ocugen to Present at BIO International Convention 2023
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Epic Bio to Participate in a Fireside Chat at the Stifel Genetic Medicines Day 2023
SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) — EPIC BIO, a biotechnology company…
Epic Bio to Participate in a Fireside Chat at the Stifel Genetic Medicines Day 2023
SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) — EPIC BIO, a biotechnology company…
Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Life Biosciences (“Life Bio”), a biotechnology company advancing…
Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Life Biosciences (“Life Bio”), a biotechnology company advancing…
T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel
The T2Biothreat Panel detects six biothreat pathogens and runs on the FDA-cleared T2Dx Instrument LEXINGTON,…
T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel
The T2Biothreat Panel detects six biothreat pathogens and runs on the FDA-cleared T2Dx Instrument LEXINGTON,…
Cogent Biosciences to Host Investor Webcast to Discuss Lead-In Data Being Presented at ASCO from the Ongoing Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST)
Webcast to be held on Monday, June 5, 2023 at 8:00 a.m. ET WALTHAM, Mass….
Cogent Biosciences to Host Investor Webcast to Discuss Lead-In Data Being Presented at ASCO from the Ongoing Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST)
Webcast to be held on Monday, June 5, 2023 at 8:00 a.m. ET WALTHAM, Mass….
NewAmsterdam to Present Full Data from ROSE2 at NLA Scientific Sessions 2023
NewAmsterdam to review data on webcast conference call on June 5, 2023 at 8:00 a.m….
NewAmsterdam to Present Full Data from ROSE2 at NLA Scientific Sessions 2023
NewAmsterdam to review data on webcast conference call on June 5, 2023 at 8:00 a.m….
Avalyn Pharma Made Corporate and Clinical Presentations at ATS 2023 Including Results of Long-Term Treatment of Pulmonary Fibrosis with AP01
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing…